BIO Investor Forum Advisory Committee
The 11th Annual BIO Investor Forum Advisory Committee will be annouced Spring 2012. Please see below for last year's committee.
10th Annual BIO Investor Forum Advisory Committee
| John Chambers |
Managing Director & Head of Healthcare Investment Banking |
Roth Capital Partners |
| Annette Grimaldi | Managing Director | BMO Capital Markets |
| James, I. Healy, MD, PhD | General Partner | Sofinnova Ventures, LLC |
| Adam Koppel, MD, PhD | Managing Director | Brookside Capital, LLC |
| Ronald W. Lennox, DPhil | Founder | CHL Medical Partners, LLC |
| Gail Maderis | President & CEO | BayBio |
| Gwen A. Melincoff |
SVP, Business Development, Strategic Investment Group |
Shire Pharmaceuticals, Inc. |
| Jeffrey M. Ostrove, PhD | President & Chief Executive Officer | Ceregene Inc. |
| Andrew J. Schwab | Founder & Managing Partner | 5AM Ventures, LLC |
| Katya Smirnyagina, PhD | Venture Partner | Alta Partners, LLC |
| Samuel Wu, MD, PhD | Managing Director | Medimmune Ventures |
| Asish K. Xavier, PhD | Vice President |
Johnson & Johnson Development Corporation |
